Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4931]

European Commission grants marketing authorisation for sacituzumab govitecan for TNBC

European Commission grants marketing authorisation for sacituzumab govitecan for TNBC

FDA approves sirolimus protein-bound particles for malignant perivascular epithelioid cell tumour

FDA approves sirolimus protein-bound particles for malignant perivascular epithelioid cell tumour

Study reveals factors in metabolism that can enhance efficiency of treatment for gynaecologic tumours

Study reveals factors in metabolism that can enhance efficiency of treatment for gynaecologic tumours

Functional precision medicine using drug sensitivity testing enables tailoring of therapy for leukaemia patients

Functional precision medicine using drug sensitivity testing enables tailoring of therapy for leukaemia patients

Using T cells to target malignant brain tumours

Using T cells to target malignant brain tumours

Synthetic immunotherapy seeks out and destroys tumours in mice with aggressive cancers

Synthetic immunotherapy seeks out and destroys tumours in mice with aggressive cancers

Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases

Combination immunotherapy improves survival for patients with asymptomatic melanoma brain metastases

FDA approve clinical trial of drug to treat eye cancer ‘from the inside out’

FDA approve clinical trial of drug to treat eye cancer ‘from the inside out’

Immunotherapy may yield longer treatment-free survival than targeted therapy in advanced renal cell carcinoma patients

Immunotherapy may yield longer treatment-free survival than targeted therapy in advanced renal cell carcinoma...

Blood tests predict which prostate cancer patients are resistant to chemotherapy drugs

Blood tests predict which prostate cancer patients are resistant to chemotherapy drugs

More from ecancer